↓ Skip to main content

Immunogenicity of BNT162b2 Vaccine Booster Dose in Patients With Inflammatory Bowel Disease Receiving Infliximab Combination Therapy: A Prospective Observational Study

Overview of attention for article published in Frontiers in Medicine, July 2022
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Immunogenicity of BNT162b2 Vaccine Booster Dose in Patients With Inflammatory Bowel Disease Receiving Infliximab Combination Therapy: A Prospective Observational Study
Published in
Frontiers in Medicine, July 2022
DOI 10.3389/fmed.2022.933996
Pubmed ID
Authors

Mohammad Shehab, Fatema Alrashed, Ahmad Alfadhli, Abdulwahab Alsayegh, Usama Aldallal, Mariam Alsayegh, Preethi Cherian, Irina Alkhair, Thangavel Alphonse Thanaraj, Arshad Channanath, Ali A. Dashti, Anwar Albanaw, Hamad Ali, Mohamed Abu-Farha, Jehad Abubaker, Fahd Al-Mulla

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 20%
Student > Ph. D. Student 1 10%
Student > Doctoral Student 1 10%
Lecturer 1 10%
Unknown 5 50%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 30%
Medicine and Dentistry 2 20%
Unknown 5 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2022.
All research outputs
#13,734,646
of 22,792,160 outputs
Outputs from Frontiers in Medicine
#2,210
of 5,621 outputs
Outputs of similar age
#187,777
of 434,604 outputs
Outputs of similar age from Frontiers in Medicine
#193
of 576 outputs
Altmetric has tracked 22,792,160 research outputs across all sources so far. This one is in the 38th percentile – i.e., 38% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,621 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.0. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,604 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 576 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.